Cart is empty An artificial intelligence (AI) tool developed at Vanderbilt University Medical Center accurately identified pediatric patients at high risk for blood clots in a clinical trial. However, there was no difference in outcomes compared to a control group, the researchers reported in JAMA Network Open.
Leave A Comment